Data Foundry

Drug recalls 2016

Pramipexole Dihydrochloride Tablets 0 — Class II drug recall D-0653-2016

Terminated recall by Macleods Pharma Usa Inc, reported 2016-02-17, distributed nationwide. Presence of Foreign Tablets/Capsules: Presence of a comingled Carbimazole 5 mg tablet.

Recall numberD-0653-2016
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmMacleods Pharma Usa Inc, Plainsboro, NJ, United States
Recall initiated2015-12-24
Classified2016-02-05
Reported by FDA2016-02-17
Terminated2020-08-31
DistributedNationwide (US)
NDC33342-0031, 33342-0031-06, 33342-0031-10, 33342-0031-12, 33342-0031-15, 33342-0032, 33342-0032-06, 33342-0032-10, 33342-0032-12, 33342-0032-15, 33342-0033, 33342-0033-06, 33342-0033-10, 33342-0033-12, 33342-0033-15, 33342-0034, 33342-0034-06, 33342-0034-10, 33342-0034-12, 33342-0034-15, 33342-0035, 33342-0035-06, 33342-0035-10, 33342-0035-12, 33342-0035-15
Lot numbersBPA512A
Expiration dates2017-06

Product

Pramipexole Dihydrochloride Tablets 0.125 mg, 90 Ct Bottles, Rx Only. Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA. NDC: 33342-031-10.

Reason for recall

Presence of Foreign Tablets/Capsules: Presence of a comingled Carbimazole 5 mg tablet.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0653-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.